Chinese patent medicine granules package traditional multi-herb formulas into a convenient dissolve-and-take form. Products such as Shenling Jianpiwei Granule, supplied here in 5 g sachets, sit within a regulated category that requires registration, standardized manufacturing, and documented quality control. This article outlines the regulatory framework buyers should understand.

Registration and Market Authorization

In China, finished herbal medicines are regulated as Chinese patent medicines and must hold a registration approval before legal manufacture and sale. Each approved product carries a defined formula, specification, and indications scope. For export, the product's status in the destination market, whether supplement, food, or medicine, determines the import pathway and required documentation.

Good Manufacturing Practice Requirements

Granule manufacturing must occur in facilities certified for good manufacturing practice. The process includes extraction, concentration, granulation, and drying under controlled conditions to maintain consistency. GMP documentation covers sanitation, equipment qualification, and batch records, all of which support traceability from raw herb to finished sachet.

Quality Control and Marker Testing

Because granules are concentrated herbal blends, regulators and manufacturers apply identity and content testing. Methods such as thin-layer chromatography confirm botanical identity, while quantitative assays verify marker compounds. These controls ensure that each 5 g sachet delivers a consistent composition rather than a variable crude mixture.

Labeling and Responsible Distribution

Accurate labeling, including an ingredient list, batch number, expiry, and an intended-use statement, is both a regulatory requirement and a distribution safeguard. Responsible suppliers avoid unsubstantiated therapeutic claims and present the product within its approved scope, protecting downstream buyers from compliance exposure.

Post-Market Surveillance and Batch Release

Regulators expect manufacturers to maintain pharmacovigilance and adverse-event reporting even for traditional formulations, and batch release depends on meeting the approved specification each time. Importers should retain the registration and batch documentation for the period required in their market so that any quality query can be traced quickly. This documentation discipline is what separates compliant distribution from informal trading.

FAQ

Q: How are Chinese patent medicine granules authorized? A: They require registration approval defining the formula, strength, and indication scope, and for export the destination market classification sets the import requirements.

Q: What quality tests apply to herbal granules? A: Identity testing such as chromatography and quantitative marker assays verify that each batch matches its specified composition and potency.

Q: Why does GMP matter for granule products? A: GMP controls extraction, granulation, and drying conditions, ensuring batch-to-batch consistency and full traceability from raw herb to finished sachet.